A Critical Need to Reconsider Cancer Trial Eligibility Requirements.
- Published in:
- Oncology, 2010, v. 79, n. 1/2, p. 1, doi. 10.1159/000319554
- By:
- Publication type:
- Article
Works matching IS 00302414 AND DT 2010 AND VI 79 AND IP 1/2
Results: 21
1
2
Trimodal Therapy for Inflammatory Breast Cancer: A Surgeon's Perspective.
- Published in:
- Oncology, 2010, v. 79, n. 1/2, p. 3, doi. 10.1159/000318529
- By:
- Publication type:
- Article
3
Women and Bone Health: Maximizing the Benefits of Aromatase Inhibitor Therapy.
- Published in:
- Oncology, 2010, v. 79, n. 1/2, p. 13, doi. 10.1159/000314997
- By:
- Publication type:
- Article
4
Increased Risk of Serious Hemorrhage with Bevacizumab in Cancer Patients: A Meta-Analysis.
- Published in:
- Oncology, 2010, v. 79, n. 1/2, p. 27, doi. 10.1159/000314980
- By:
- Publication type:
- Article
5
Treatment Efficacy/Safety and Prognostic Factors in Patients with Advanced Biliary Tract Cancer Receiving Gemcitabine Monotherapy: An Analysis of 100 Cases.
- Published in:
- Oncology, 2010, v. 79, n. 1/2, p. 39, doi. 10.1159/000318020
- By:
- Publication type:
- Article
6
Palliative Chemotherapy Does Not Improve Survival in Metastatic Esophageal Cancer.
- Published in:
- Oncology, 2010, v. 79, n. 1/2, p. 46, doi. 10.1159/000318029
- By:
- Publication type:
- Article
7
Expression of Estrogen Receptor Beta and Phosphorylation of Estrogen Receptor Alpha Serine 167 Correlate with Progression-Free Survival in Patients with Metastatic Breast Cancer Treated with Aromatase Inhibitors.
- Published in:
- Oncology, 2010, v. 79, n. 1/2, p. 55, doi. 10.1159/000319540
- By:
- Publication type:
- Article
8
Safety and Feasibility of Using Sorafenib in Recurrent Hepatocellular Carcinoma after Orthotopic Liver Transplantation.
- Published in:
- Oncology, 2010, v. 79, n. 1/2, p. 62, doi. 10.1159/000319548
- By:
- Publication type:
- Article
9
Stop and Go FOLFOX plus Bevacizumab Chemotherapy in the First-Line Treatment of Metastatic Colorectal Cancer.
- Published in:
- Oncology, 2010, v. 79, n. 1/2, p. 67, doi. 10.1159/000319549
- By:
- Publication type:
- Article
10
Cisplatin Application in Pregnancy: First in vivo Analysis of 7 Patients.
- Published in:
- Oncology, 2010, v. 79, n. 1/2, p. 72, doi. 10.1159/000320156
- By:
- Publication type:
- Article
11
Prognostic Model to Predict Outcomes in Non-Small Cell Lung Cancer Patients with Erlotinib as Salvage Treatment.
- Published in:
- Oncology, 2010, v. 79, n. 1/2, p. 78, doi. 10.1159/000320190
- By:
- Publication type:
- Article
12
Sunitinib in Patients with Advanced Hepatocellular Carcinoma after Progression under Sorafenib Treatment.
- Published in:
- Oncology, 2010, v. 79, n. 1/2, p. 85, doi. 10.1159/000320363
- By:
- Publication type:
- Article
13
Equivalence of Pegfilgrastim and Filgrastim in Lymphoma Patients Treated with BEAM Followed by Autologous Stem Cell Transplantation.
- Published in:
- Oncology, 2010, v. 79, n. 1/2, p. 93, doi. 10.1159/000320604
- By:
- Publication type:
- Article
14
Bevacizumab plus Low-Dose Metronomic Oral Cyclophosphamide in Heavily Pretreated Patients with Recurrent Ovarian Cancer.
- Published in:
- Oncology, 2010, v. 79, n. 1/2, p. 98, doi. 10.1159/000320602
- By:
- Publication type:
- Article
15
Does the Metastatic Lymph Node Ratio Influence the Disease-Free Survival of Patients with Breast Cancer: Single-Center Experiences.
- Published in:
- Oncology, 2010, v. 79, n. 1/2, p. 105, doi. 10.1159/000320162
- By:
- Publication type:
- Article
16
Assessment of Fatigue in Cancer Patients and Community Dwellers: Validation Study of the Filipino Version of the Brief Fatigue Inventory.
- Published in:
- Oncology, 2010, v. 79, n. 1/2, p. 112, doi. 10.1159/000320607
- By:
- Publication type:
- Article
17
Bevacizumab plus Irinotecan-Based Regimens in the Treatment of Metastatic Colorectal Cancer.
- Published in:
- Oncology, 2010, v. 79, n. 1/2, p. 118, doi. 10.1159/000314993
- By:
- Publication type:
- Article
18
A Single-Arm Phase II Trial of First-Line Paclitaxel in Combination with Lapatinib in HER2-Overexpressing Metastatic Breast Cancer.
- Published in:
- Oncology, 2010, v. 79, n. 1/2, p. 129, doi. 10.1159/000318043
- By:
- Publication type:
- Article
19
Oxaliplatin-Free Interval as a Risk Factor for Hypersensitivity Reaction among Colorectal Cancer Patients Treated with FOLFOX.
- Published in:
- Oncology, 2010, v. 79, n. 1/2, p. 136, doi. 10.1159/000320613
- By:
- Publication type:
- Article
20
High Plasma TIMP-1 and Serum CEA Levels during Combination Chemotherapy for Metastatic Colorectal Cancer Are Significantly Associated with Poor Outcome.
- Published in:
- Oncology, 2010, v. 79, n. 1/2, p. 144, doi. 10.1159/000320686
- By:
- Publication type:
- Article
21
Rechallenge with Platinum plus Fluoropyrimidine +/- Epirubicin in Patients with Oesophagogastric Cancer.
- Published in:
- Oncology, 2010, v. 79, n. 1/2, p. 150, doi. 10.1159/000322114
- By:
- Publication type:
- Article